Trial NCT01683656

View at ClinicalTrials.gov 
Org. Study IDs: NILACH 2012DR4097

Last trial update was posted on 2019-10-08

MeSH Interventions

Niacin

MeSH Conditions

Atherosclerosis

Other Conditions

HIV

Stopping Reasons

Withdrawal of IMP from the market. Data on risk-benefit ratio pending.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID